Ventolin Injection 0.5 Mg 5 Amp
Brand : glaxo smith kline pakistan
How it works
Salbutamol is a selective beta2 adrenoceptor agonist. At therapeutic doses it acts on the beta2 adrenoceptors of bronchial muscle providing short acting (4 to 6 hour) bronchodilation in reversible airways obstruction.
VENTOLIN INJ 0.5 MG 5 AMP
Requires Prescription (YES/NO)
Salbutamol are indicated for the relief of bronchospasm in bronchial asthma of all types, chronic bronchitis and emphysema.
Immune system disorders - Very rare: Hypersensitivity reactions including angioedema, urticaria, bronchospasm, hypotension and collapse.Metabolism and nutrition disorders - Rare: Hypokalaemia. Potentially serious hypokalaemia may result from beta2 agonist therapy.Nervous system disorders - Very common: Tremor. Common: Headache. Very rare: Hyperactivity.Cardiac disorders - Common: Tachycardia, palpitations. Rare: Cardiac arrhythmias including atrial fibrillation, supraventricular tachycardia and extrasystoles.Vascular disorders- Rare: Peripheral vasodilatation.Musculoskeletal and connective tissue disorders - Common: Muscle cramps. Very rare: Feeling of muscle tension.
When not to Use
It is contra-indicated in patients with a history of hypersensitivity to any of their components. Non-i.v. formulations of must not be used to arrest uncomplicated premature labour or threatened abortion.
Severe bronchospasm and status asthmatic : Adults : 8 mcg/kg SC or IM four hourly , or 4 mcg/kg by slow IV inj repeated if necessary. Children : Management of Acute Asthma : By IV injecction over 5 minutes : 1 mnth-2yr , 5mcg/kg as a single dose; 2-18yr, 15mcg/kg, max 250mcg as a single dose. Continuous IV infusion; 1 mnth-18yr, 1-2 mg/kg/minute, adjusted according to response and heart rate upto 5mcg/kg/minute ; doses above 2mcg/kg/minute should be given in an intensive care setting. OR As directed by your physician.
Storage yes or /no
Store this medicine at room temperature, away from direct light and heat.
Potentially serious hypokalaemia may result from beta2 agonist Particular caution is advised in acute severe asthma as this effect may be potentiated by concomitant treatment with xanthine derivatives, steroids, diuretics and by hypoxia. It is recommended that serum potassium levels are monitored in such situations.therapy mainly from parenteral and nebulised administration.
The management of asthma should normally follow a stepwise programme, and patient response should be monitored clinically and by lung function tests .
Increasing use of short-acting inhaled beta2 agonists to control symptoms indicates deterioration of asthma control. Under these conditions, the patient's therapy plan should be reassessed. Sudden and progressive deterioration in asthma control is potentially lifethreatening and consideration should be given to starting or increasing corticosteroid therapy. In patients considered at risk, daily peak flow monitoring may be instituted.
Patients should be warned that if either the usual relief is diminished or the usual duration of action reduced, they should not increase the dose or its frequency of administration, but should seek medical advice.
Always consult your physician before using any medicine.
Propranolol , monoamine oxidase inhibitors (MAOIs) , digoxin , theophylline or aminophylline) , prednisolone , (such as frusemide) , such as insulin, metformin or glibenclamide .
syr bd 1cc insulin 6mm syringe 1s
disprin 300mg dispersible tablets 100s (pack size 10 x 10s)
panadol 500mg tablets 200s ( pack size 20x10s)